MIC
RVMD icon

Mubadala Investment Company’s Revolution Medicines RVMD Stock Holding History

Mubadala Investment Company’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-278,000
Closed -$10.8M – 18
2024
Q2 		$10.8M Hold
278,000
– – 0.04% 14
2024
Q1 		$8.96M Hold
278,000
– – 0.04% 15
2023
Q4 		$7.97M Buy
+278,000
New +$6.68M 0.03% 16

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mubadala Investment Company's RVMD Position: Q3 2024 in Review

Mubadala Investment Company sold out of Revolution Medicines (RVMD) in Q3 2024, closing a stake of 278,000 shares — an estimated $10.8M sold.

Mubadala Investment Company first reported a position in RVMD in Q4 2023 and held it in 3 quarters. The position peaked at $10.8M in Q2 2024. 255 funds tracked by Wall St. Rank hold RVMD as of Q3 2024.

  • Mubadala Investment Company reported no remaining Revolution Medicines position as of Q3 2024 after selling out during the quarter.
  • Mubadala Investment Company sold 278,000 Revolution Medicines shares in Q3 2024, an estimated $10.8M.
  • Mubadala Investment Company first reported a position in Revolution Medicines in Q4 2023 and held it in 3 quarters.
  • Mubadala Investment Company's Revolution Medicines position peaked at $10.8M in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2024.

Based on Mubadala Investment Company's 13F filing for Q3 2024, filed 13 Nov 2024.